CABIRALIZUMAB
UNII 5FJL6W0640

Substance Identification & Data

This profile provides standardized clinical and technical data for Cabiralizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5FJL6W0640.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1613144-80-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
5FJL6W0640
CAS Registry Number
1613144-80-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CABIRALIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C123831
National Cancer Institute reference terminology for clinical and research data.
INN ID
10121
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cabiralizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CABIRALIZUMAB

Common Names & Synonyms

CABIRALIZUMAB [INN]
CABIRALIZUMAB [WHO-DD]
FPA008
FPA-008
IMMUNOGLOBULIN G4, ANTI-(MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL FPA008 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL FPA008 LIGHT CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus